Literature DB >> 10849424

Lipid phosphate phosphatase-1 and Ca2+ control lysophosphatidate signaling through EDG-2 receptors.

J Xu1, L M Love, I Singh, Q X Zhang, J Dewald, D A Wang, D J Fischer, G Tigyi, L G Berthiaume, D W Waggoner, D N Brindley.   

Abstract

The serum-derived phospholipid growth factor, lysophosphatidate (LPA), activates cells through the EDG family of G protein-coupled receptors. The present study investigated mechanisms by which dephosphorylation of exogenous LPA by lipid phosphate phosphatase-1 (LPP-1) controls cell signaling. Overexpressing LPP-1 decreased the net specific cell association of LPA with Rat2 fibroblasts by approximately 50% at 37 degrees C when less than 10% of LPA was dephosphorylated. This attenuated cell activation as indicated by diminished responses, including cAMP, Ca(2+), activation of phospholipase D and ERK, DNA synthesis, and cell division. Conversely, decreasing LPP-1 expression increased net LPA association, ERK stimulation, and DNA synthesis. Whereas changing LPP-1 expression did not alter the apparent K(d) and B(max) for LPA binding at 4 degrees C, increasing Ca(2+) from 0 to 50 micrometer increased the K(d) from 40 to 900 nm. Decreasing extracellular Ca(2+) from 1.8 mm to 10 micrometer increased LPA binding by 20-fold, shifting the threshold for ERK activation to the nanomolar range. Hence the Ca(2+) dependence of the apparent K(d) values explains the long-standing discrepancy of why micromolar LPA is often needed to activate cells at physiological Ca(2+) levels. In addition, the work demonstrates that LPP-1 can regulate specific LPA association with cells without significantly depleting bulk LPA concentrations in the extracellular medium. This identifies a novel mechanism for controlling EDG-2 receptor activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10849424     DOI: 10.1074/jbc.M003211200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Pulmonary lipid phosphate phosphohydrolase in plasma membrane signalling platforms.

Authors:  M Nanjundan; F Possmayer
Journal:  Biochem J       Date:  2001-09-15       Impact factor: 3.857

2.  Phosphatidic acid mediates activation of mTORC1 through the ERK signaling pathway.

Authors:  Jeremiah N Winter; Todd E Fox; Mark Kester; Leonard S Jefferson; Scot R Kimball
Journal:  Am J Physiol Cell Physiol       Date:  2010-04-28       Impact factor: 4.249

3.  Expression of ectolipid phosphate phosphohydrolases in 3T3F442A preadipocytes and adipocytes. Involvement in the control of lysophosphatidic acid production.

Authors:  Marie Francoise Simon; Astrid Rey; Isabelle Castan-Laurel; Sandra Grés; David Sibrac; Philippe Valet; Jean Sébastien Saulnier-Blache
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

4.  Sphingosine 1-phosphate pKa and binding constants: intramolecular and intermolecular influences.

Authors:  Mor M Naor; Michelle D Walker; James R Van Brocklyn; Gabor Tigyi; Abby L Parrill
Journal:  J Mol Graph Model       Date:  2007-03-14       Impact factor: 2.518

5.  A lysophosphatidic acid analogue is revealed as a potent inhibitor of phosphatidylcholine synthesis, inducing apoptosis.

Authors:  Geneviéve Gueguen; Virginie Granci; Pierre Rogalle; Fabienne Briand-Mésange; Michéle Wilson; Alain Klaébé; François Tercé; Hugues Chap; Jean-Pierre Salles; Marie-Françoise Simon; Frédérique Gaits
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

6.  LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cystadenocarcinoma by activating the PI3K/AKT signaling pathway.

Authors:  Ran Cui; Guangming Cao; Huimin Bai; Zhenyu Zhang
Journal:  Cancer Cell Int       Date:  2019-07-29       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.